Pharma

Your Article Summary

See Latest Articles

GlaxoSmithKline and Theravance commence Phase III Horizon programme to develop a next-generation treatment for COPD
GlaxoSmithKline, 10/28/09

GlaxoSmithKline and Theravance, Inc. announced that the first patient has commenced treatment as part of the Phase III programme being undertaken to develop a next–generation combination treatment for patients with chronic obstructive pulmonary disorder, a leading cause of chronic illness and death.

Today in Research & Development...keeping you current

Receive free subspecialty "5-minute updates" via email

Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09

Bayer CropScience signs Agreement with GVK Biosciences on early-stage research projects
BayNews International, 11/25/09

Reports Rate Ambulatory EHR Software
HealthDataManagement, 11/25/09

 See all of Research & Development